Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03875456
Other study ID # RECHMPL19_0107
Secondary ID
Status Completed
Phase
First received
Last updated
Start date December 1, 2018
Est. completion date March 1, 2019

Study information

Verified date March 2019
Source University Hospital, Montpellier
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The cephalohematoma is a common pathology of newborns. Observation is the primary treatment for the most of small uncomplicated cephalohematoma. However large cephalohematoma can lead to calcification with anesthetic local deformation or deformational plagiocephaly. The objective of the study was to evaluate the iatrogenic risk associated with early puncture on local anesthesia.


Description:

This is a retrospective study of 67 newborns followed at the University Hospital of Montpellier between 2010 and 2017. Treatment was puncture under local anesthesia between 2 and 4 weeks of life.

Any potential complication events were searched retrospectively during the month after the puncture. Analyze of the electronic medical record was made as followed: read of peri-operative and post-operative reports, looking for readmission in Pediatric Emergency department and finally read of the report of the clinical control 1 month after the procedure


Recruitment information / eligibility

Status Completed
Enrollment 67
Est. completion date March 1, 2019
Est. primary completion date February 1, 2019
Accepts healthy volunteers No
Gender All
Age group N/A to 30 Days
Eligibility Inclusion criteria:

- diagnosis of cephalohematoma was performed by the two senior plastic pediatric surgeon of the study

- the diagnosis was confirmed by ultrasound examination

Exclusion criteria:

- Skull fracture (seen by ultrasound examination)

- Intra-cranial complication (ultrasound examination)

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
France Uhmontpellier Montpellier

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Montpellier

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Complication events during the month after the puncture. retrospective data collection. Analyze of the electronic medical record was made as followed: read of peri-operative and post-operative reports, looking for readmission in Pediatric Emergency department and finally read of the report of the clinical control 1 month after the procedure 1 day